Associations Between Neuromuscular Fatigue, Anxiety, and Peripheral Biomarkers of Neuronal Injury, Inflammation, and Mitochondrial Dysfunction in Treatment‐Naïve Relapsing‐Remitting Multiple Sclerosis
Aug 2026· Brain and Behavior· Vol 16· 0 citations· 90 references
Medicine
Abstract
To investigate whether neuromuscular fatigue and anxiety are associated with a peripheral biological signature involving inflammation, oxidative stress, mitochondrial homeostasis, neurotrophic support, and neuronal/glial injury markers in treatment‐naïve patients with relapsing‐remitting multiple sclerosis (RRMS).
Cancer‐related fatigue (CRF) is a prevalent and disabling symptom across the cancer continuum and is increasingly conceptualized as a biobehavioral symptom with inflammatory underpinnings. However, evidence linking specific circulating inflammatory biomarkers to CRF remains fragmented and inconsistent.
This review aims to evaluate the mechanistic basis, clinical efficacy, and safety profile of oxiracetam as a potential therapeutic agent for cognitive dysfunction across a range of neurological disorders.
Hafsa Ali, Syeda Maliha, Sundas Ishtiaq et al.· Brain and Behavior· 0 citations
This study evaluated whether circulating concentrations of vasoactive intestinal peptide, interleukin‐1β (IL‐1β), and tumor necrosis factor‐alpha (TNF‐α) differed according to the presence of anxiety and depressive symptoms among individuals with PD.
Liang-Yu Li, Xiao-Yang Jia, Ying-Chang Shi et al.· Brain and Behavior· 0 citations
: Tic disorder represents a prevalent neurodevelopmental disorder, yet conventional pharmacotherapy frequently causes notable adverse effects. Anti ‑ inflammatory diets show therapeutic promise for neuropsychiatric conditions through modulating gut microbiota and relieving neuro inflammation and oxidative stress. This...
Plasma and cerebrospinal fluid (CSF) protein biomarkers in amyotrophic lateral sclerosis (ALS) may provide insight into disease mechanisms and yield clinically useful biomarkers.
Lu Pan, C. Hou, Christina Seitz et al.· European Journal of Neurolog...· 0 citations
Despite compelling epidemiological, genetic and cellular evidence linking immune dysregulation to depression and schizophrenia (and other psychotic disorders), causality remains contested and no immune biomarker has yet demonstrated robust clinical utility. Emerging methodological approaches - from target trial emulati...
T. Formánek, M. Lynall, E. Osimo· The British journal of psych...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.